High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis:insights from SATURN. Stegman B,Puri R,Cho L,et al. Diabetes Care . 2014Stegman B, Puri R, Cho L, Shao M, Ballantyne CM, Barter PJ, et al. High- intensity statin therapy alters the natural ...
Accordingly, we designed the ASTEROID trial (A Study to Evaluate the Effect of Rosuvastatin on Intravascular Ultrasound-Derived Coronary Atheroma Burden) to examine the effects of high-intensity statin therapy on IVUS-derived measures of coronary disease progression. Rosuvastatin is the most recently ...
2022 Alirocumab Added to High-Intensity Statin Therapy and Coronary Atherosclerosis in Patients With Acute Myocardial Infarction JAMA Comment & Response September 6, 2022 Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease JAMA Original Investigation April 4, 2023 This rando...
Benes LB, Bassi NS, Davidson MH. The risk of hepatotox- icity, new onset diabetes and rhabdomyolysis in the era of high-intensity statin therapy: does statin type mat- ter? Progress Cardiovasc Dis 2016; 59: 145-52.Benes, L. B., Bassi, N. S., and Davidson, M. H. (2016). The ...
Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis: The ASTEROID Trial Prior intravascular ultrasound (IVUS) trials have demonstrated slowing or halting of atherosclerosis progression with statin therapy but have not shown con... M Clearfield - 《Current Atherosclerosis...
Effect of Ezetimibe Added to High-Intensity Statin Therapy on Low-Density Lipoprotein Cholesterol Levels_ A Meta-Analysis_2021_J 上传人:jrlib7·上传时间:2022-11-27 继续阅读
3-5 Many patients receiving moderate- or high-intensity statin therapy are unable to achieve these recommended goals with statin therapy, and consideration of nonstatin therapy for additional LDL-C lowering has been recommended.4-8 Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors ...
2023 This randomized clinical trial compares the efficacy of a treat-to-target low-density lipoprotein cholesterol (LDL-C) strategy of 50 to 70 mg/dL as the goal vs high-intensity statin therapy for the 3-year composite of death, myocardial infarction, stroke, or coronary revascularization in ...
which now recommend high-intensity statin therapy be initiated or continued as first-line treatment in both women and men who have ischemic stroke, unless contraindicated.9–11 In parallel, the affordability and avail- ability of high-intensity statins was increased as the patent for atorvastatin ex...
Although epicardial adipose tissue thickness at systole can be a useful marker for predicting NOD during high‑intensity statin therapy in a previous study, there are inconsistent findings with the pitvastatin [22]. Mechanisms of pitavastatin Previous studies have suggested several mechanisms of the ...